431 related articles for article (PubMed ID: 23223017)
1. Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.
Valencia A; Sapp E; Kimm JS; McClory H; Reeves PB; Alexander J; Ansong KA; Masso N; Frosch MP; Kegel KB; Li X; DiFiglia M
Hum Mol Genet; 2013 Mar; 22(6):1112-31. PubMed ID: 23223017
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.
Li X; Valencia A; Sapp E; Masso N; Alexander J; Reeves P; Kegel KB; Aronin N; Difiglia M
J Neurosci; 2010 Mar; 30(13):4552-61. PubMed ID: 20357106
[TBL] [Abstract][Full Text] [Related]
3. Multiple phenotypes in Huntington disease mouse neural stem cells.
Ritch JJ; Valencia A; Alexander J; Sapp E; Gatune L; Sangrey GR; Sinha S; Scherber CM; Zeitlin S; Sadri-Vakili G; Irimia D; Difiglia M; Kegel KB
Mol Cell Neurosci; 2012 May; 50(1):70-81. PubMed ID: 22508027
[TBL] [Abstract][Full Text] [Related]
4. Acute exposure to chlorpyrifos caused NADPH oxidase mediated oxidative stress and neurotoxicity in a striatal cell model of Huntington's disease.
Dominah GA; McMinimy RA; Kallon S; Kwakye GF
Neurotoxicology; 2017 May; 60():54-69. PubMed ID: 28300621
[TBL] [Abstract][Full Text] [Related]
5. Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington's disease mice.
McClory H; Williams D; Sapp E; Gatune LW; Wang P; DiFiglia M; Li X
Acta Neuropathol Commun; 2014 Dec; 2():179. PubMed ID: 25526803
[TBL] [Abstract][Full Text] [Related]
6. Striatal synaptosomes from Hdh140Q/140Q knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation.
Valencia A; Sapp E; Kimm JS; McClory H; Ansong KA; Yohrling G; Kwak S; Kegel KB; Green KM; Shaffer SA; Aronin N; DiFiglia M
J Huntingtons Dis; 2013; 2(4):459-75. PubMed ID: 24696705
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase.
Chéret C; Gervais A; Lelli A; Colin C; Amar L; Ravassard P; Mallet J; Cumano A; Krause KH; Mallat M
J Neurosci; 2008 Nov; 28(46):12039-51. PubMed ID: 19005069
[TBL] [Abstract][Full Text] [Related]
8. Deficient Rab11 activity underlies glucose hypometabolism in primary neurons of Huntington's disease mice.
Li X; Valencia A; McClory H; Sapp E; Kegel KB; Difiglia M
Biochem Biophys Res Commun; 2012 May; 421(4):727-30. PubMed ID: 22542623
[TBL] [Abstract][Full Text] [Related]
9. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidases as potential pharmacological targets against increased seizure susceptibility after systemic inflammation.
Huang WY; Lin S; Chen HY; Chen YP; Chen TY; Hsu KS; Wu HM
J Neuroinflammation; 2018 May; 15(1):140. PubMed ID: 29753328
[TBL] [Abstract][Full Text] [Related]
11. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
[TBL] [Abstract][Full Text] [Related]
12. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
13. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
14. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
[TBL] [Abstract][Full Text] [Related]
15. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
16. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
[TBL] [Abstract][Full Text] [Related]
17. Protein changes in synaptosomes of Huntington's disease knock-in mice are dependent on age and brain region.
Sapp E; Seeley C; Iuliano M; Weisman E; Vodicka P; DiFiglia M; Kegel-Gleason KB
Neurobiol Dis; 2020 Jul; 141():104950. PubMed ID: 32439598
[TBL] [Abstract][Full Text] [Related]
18. NOX2-derived reactive oxygen species are crucial for CD29-induced pro-survival signalling in cardiomyocytes.
Rosc-Schlüter BI; Häuselmann SP; Lorenz V; Mochizuki M; Facciotti F; Pfister O; Kuster GM
Cardiovasc Res; 2012 Mar; 93(3):454-62. PubMed ID: 22198504
[TBL] [Abstract][Full Text] [Related]
19. Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase.
Fan L; Sawbridge D; George V; Teng L; Bailey A; Kitchen I; Li JM
J Pharmacol Exp Ther; 2009 Jan; 328(1):99-106. PubMed ID: 18952886
[TBL] [Abstract][Full Text] [Related]
20. NOX2 deficiency ameliorates cerebral injury through reduction of complexin II-mediated glutamate excitotoxicity in experimental stroke.
Wang Z; Wei X; Liu K; Zhang X; Yang F; Zhang H; He Y; Zhu T; Li F; Shi W; Zhang Y; Xu H; Liu J; Yi F
Free Radic Biol Med; 2013 Dec; 65():942-951. PubMed ID: 23982049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
